In emergency department patients presenting with septic shock, longer delays in administering antibiotics and initiating vasopressors are both independently associated with increased in-hospital mortality, according to a fifteen-year retrospective cohort study conducted at a tertiary hospital in South Korea. The investigation evaluated whether one intervention timing demonstrated a stronger association with patient survival than the other, concluding that the per-hour mortality associations between time-to-antibiotics and time-to-vasopressor were statistically indistinguishable. The investigators noted that achieving both resuscitation milestones within three hours was associated with significantly reduced mortality compared with failing to achieve both targets, while claiming no clinical superiority of one resuscitation timing over the other.
Furthermore, the comparative clinical associations of rapid antimicrobial delivery versus timely haemodynamic resuscitation using vasopressor therapy have remained unclear in emergency care settings. The research team sought to clarify these relationships by examining the independent and joint associations of time-to-antibiotics and time-to-vasopressor with in-hospital mortality, while also tracking whether these associations varied across a fifteen-year timeframe.
The investigation analyzed clinical records collected between 2011 and 2025 at a single Korean tertiary hospital emergency department. Within this patient population, the median age was 74 years, and men accounted for 54.4 percent of the sample. Across the entire cohort of 2,086 emergency department patients, the overall in-hospital mortality rate was recorded at 29.6 percent.
The median time-to-antibiotics across the evaluated population was 1.58 hours following emergency department arrival. In comparison, the median time-to-vasopressor initiation was 2.33 hours from hospital presentation.
In the primary multivariable regression model adjusting strictly for pre-treatment baseline variables, both treatment intervals demonstrated statistically significant independent associations with patient mortality. For each one-hour delay in antibiotic administration, the adjusted odds ratio for in-hospital mortality was 1.042, with a 95 percent confidence interval ranging from 1.015 to 1.068 (p = 0.002). For each one-hour delay in initiating vasopressor support, the adjusted odds ratio was 1.024, with a 95 percent confidence interval ranging from 1.015 to 1.034 (p < 0.001). When researchers conducted a formal Wald contrast test to directly compare the magnitude of the two per-hour regression coefficients, the comparison yielded a p-value of 0.25, indicating no statistically significant difference between the prognostic impact of an hourly antibiotic delay and an hourly vasopressor delay.
Beyond evaluating single-agent delays, the research group utilized inverse-probability-of-treatment weighting to examine the clinical impact of achieving dual resuscitation benchmarks, defined as achieving both time-to-antibiotics under three hours and time-to-vasopressor under three hours. In this weighted analysis, attaining both clinical targets was associated with a weighted in-hospital mortality rate of 24.1 percent, compared to 34.1 percent among patients who did not attain both targets. This corresponded to a statistically significant weighted risk difference of 10.0 percentage points, with a 95 percent confidence interval of 6.2 to 14.2 percentage points, and an adjusted odds ratio of 0.61 (95 percent confidence interval 0.50 to 0.76, p < 0.001). Additionally, exploratory continuous calendar-year interaction analyses revealed that these prognostic associations remained consistent across the study window, showing no statistically significant change over the fifteen years from 2011 to 2025 for antibiotic timing (year-by-TTA p = 0.39) or vasopressor timing (year-by-TTV p = 0.55).
In their concluding assessment, the authors emphasized that longer time-to-antibiotics and time-to-vasopressor were independently associated with higher in-hospital mortality following mutual adjustment, but underscored that neither therapy timing should be claimed as superior over the other. The authors acknowledged inherent methodological boundaries, noting that the investigation was an observational, single-centre retrospective cohort study conducted at one tertiary emergency department.
Subject of Research: Associations of antibiotic and vasopressor timing with mortality in septic shock
Article Title: Comparative associations of vasopressor and antibiotic timing with mortality in emergency department patients with septic shock: a 15-year single-centre retrospective cohort study
Article References: Kim, Y., Bae, S., Nam, E., & Kim, S.-W. (2026). Comparative associations of vasopressor and antibiotic timing with mortality in emergency department patients with septic shock: a 15-year single-centre retrospective cohort study. BMC Emergency Medicine. https://doi.org/10.1186/s12873-026-01830-2
Image Credits: AI Generated
DOI: 10.1186/s12873-026-01830-2
Keywords: septic shock, antibiotic timing, vasopressor timing, emergency department, in-hospital mortality, haemodynamic resuscitation, retrospective cohort study, time-to-antibiotics, time-to-vasopressor, Surviving Sepsis Campaign, inverse-probability-of-treatment weighting, propensity-score matching, restricted cubic splines, E-value analysis, competing-risk analysis, multivariable logistic regression, Cox regression, multiple imputation
News Source: Ophelia Keating. (November 12, 2026). Antibiotic and Vasopressor Timing Both Independently Associate With Septic Shock Mortality. Scienmag.



